Anika Therapeutics | Business Contracts

Executive Retention Agreement, dated March 9, 2020, by and between Anika Therapeutics, Inc. and David Colleran (Filed With SEC on March 16, 2023)

Description of Securities of Anika Therapeutics, Inc (Filed With SEC on March 16, 2023)

Form of Notice of Grant of Deferred Stock Awards Units, including Terms and Conditions of Deferred Stock Units, granted under Anika Therapeutics, Inc. 2021 Inducement Plan (Filed With SEC on March 11, 2022)

Lease Agreement, dated May 25, 2017, between High Properties and Parcus Medical, LLC relating to 6455 Parkland Drive, Suite 101, Sarasota, FL (Filed With SEC on March 11, 2022)

Agreement and Plan of Merger, dated January 4, 2020, by and between Anika Therapeutics, Inc., Parcus Medical, LLC, Sunshine Merger Sub, LLC and Philip Mundy (Filed With SEC on January 7, 2020)

Anika Therapeutics, Inc. 2017 Omnibus Incentive Plan (as amended effective June 8, 2022) (Filed With SEC on June 10, 2022)

Executive Retention Agreement, dated August 10, 2020, by and between Anika Therapeutics, Inc. and Michael Levitz (Filed With SEC on March 11, 2022)

Form of Notice of Grant of Restricted Stock Units Award, including Terms and Conditions of Restricted Stock Award, granted under Anika Therapeutics, Inc. 2021 Inducement Plan (Filed With SEC on March 11, 2022)

Form of Notice of Grant of Nonqualified Stock Option, including Terms and Conditions of Stock Option, granted under Anika Therapeutics, Inc. 2021 Inducement Plan (Filed With SEC on March 11, 2022)

Anika Therapeutics, Inc. Non-Employee Director Compensation Policy (restated as of February 9, 2022) (Filed With SEC on March 11, 2022)

Amendment #1 to the Lease, Renewal Amendement, dated January 4, 2018, between High Properties and Parcus Medical LLC relating to 6423 Parkland Drive, Suites 101 and 102, Sarasota,... (Filed With SEC on March 11, 2022)

Lease Agreement, dated November 26, 2012, between High Properties and Parcus Medical LLC relating to 6423 Parkland Drive, Suites 101 and 102, Sarasota, FL (Filed With SEC on March 11, 2022)

Description of Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on November 5, 2021)

Anika Therapeutics, Inc. 2021 Inducement Plan (Filed With SEC on November 5, 2021)

Form of Notice of Grant of Restricted Stock Units, including Terms and Conditions of Restricted Stock Units, granted under Anika Therapeutics, Inc. 2017 Omnibus Incentive Plan (Filed With SEC on March 5, 2021)

Form of Notice of Grant of Deferred Stock Awards Units, including Terms and Conditions of Deferred Stock Units, granted under Anika Therapeutics, Inc. 2017 Omnibus Incentive Plan (Filed With SEC on March 5, 2021)

Form of Notice of Grant of Nonqualified Stock Option, including Terms and Conditions of Stock Option, granted under Anika Therapeutics, Inc. 2017 Omnibus Incentive Plan (Filed With SEC on March 5, 2021)

Form of Notice of Grant of Incentive Stock Option, including Terms and Conditions of Stock Option, granted under Anika Therapeutics, Inc. 2017 Omnibus Incentive Plan (Filed With SEC on March 5, 2021)

Offer letter dated as of July 29, 2020 between Anika Therapeutics, Inc. and Michael Levitz (Filed With SEC on August 5, 2020)

Second Amendment effective May 14, 2020, with respect to the Credit Agreement dated as of October 24, 2017 and the Security and Pledge Agreement dated as of October 24, 2017 (Filed With SEC on May 22, 2020)

First Amendment effective August 13, 2019, with respect to the Credit Agreement dated as of October 24, 2017 and the Security and Pledge Agreement dated as of October 24, 2017 (Filed With SEC on May 22, 2020)

Employment Agreement dated as of April 23, 2020 between Anika Therapeutics, Inc. and Cheryl R. Blanchard (Filed With SEC on April 29, 2020)

Form of Notice of Grant of Deferred Stock AwardsUnits, including Terms and Conditions of Deferred Stock Units, granted under Anika Therapeutics, Inc. 2017 Omnibus Incentive Plan (Filed With SEC on March 6, 2020)

Letter agreement dated February 25, 2020, between Anika Therapeutics, Inc. and Cheryl R. Blanchard (Filed With SEC on March 2, 2020)

Agreement and Plan of Merger, dated January 4, 2020, by and between Anika Therapeutics, Inc., Arthrosurface, Inc., Button Merger Sub, Inc. and Boston Millennia Partners Button... (Filed With SEC on January 7, 2020)

Fixed Dollar Accelerated Share Repurchase Transaction, dated May 7, 2019, by and between Anika Therapeutics, Inc. and Morgan Stanley & Co. LLC (Filed With SEC on July 26, 2019)

Consulting Agreement, effective July 5, 2019, by and between Anika Therapeutics, Inc. and Edward S. Ahn, Ph.D (Filed With SEC on July 10, 2019)

Separation Agreement, effective July 8, 2019, by and between Anika Therapeutics, Inc. and Edward S. Ahn, Ph.D (Filed With SEC on July 10, 2019)

Amendment No. 2, dated April 9, 2019, to Employment Agreement, dated March 22, 2010, as amended December 8, 2010, by and between Anika Therapeutics, Inc. and Sylvia Cheung (Filed With SEC on April 12, 2019)

Executive Retention Agreement, dated April 9, 2019, by and between Anika Therapeutics, Inc. and Edward S. Ahn (Filed With SEC on April 12, 2019)

Executive Retention Agreement, dated April 9, 2019, by and between Anika Therapeutics, Inc. and Thomas Finnerty (Filed With SEC on April 12, 2019)

Amendment No. 2, dated April 9, 2019, to Employment Agreement, dated July 27, 2017, as amended March 8, 2018, by and between Anika Therapeutics, Inc. and Joseph G. Darling (Filed With SEC on April 12, 2019)

Anika Therapeutics (32)